Abstract
Mouse erythrocyte (M) rosette formation and colchicine sensitivity were compared for their ability to differentiate chronic lymphocytic leukaemia (CLL) from B cell non-Hodgkin's lymphoma (NHL) with overspill. Twenty-two cases of CLL and eight of NHL were studied along with 31 normal adults. Results from the patients in both tests differed significantly from the controls but colchicine sensitivity failed to differentiate them further. M Rosettes, on the other hand, while increased in some patients with NHL were, without overlap, much more numerous in those with CLL, and clearly distinguished the two conditions. A significant autolymphocytotoxic effect of plasma from both study groups was also noted which was not found in the controls.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burns G. F., Cawley J. C. Spontaneous mouse erythrocyte-rosette formation: correlation with surface immunoglobulin phenotype in hairy-cell leukaemia. Clin Exp Immunol. 1980 Jan;39(1):83–89. [PMC free article] [PubMed] [Google Scholar]
- Dickson A. Lymphocytotoxins in leukaemia. Br Med J. 1972 Oct 28;4(5834):209–211. doi: 10.1136/bmj.4.5834.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dobozy A., Hunyadi J., Krizsa F., Kenderessy A. S., Simon N. A comparative study of the shedding process mouse erythrocyte binding receptors on peripheral blood lymphocytes from healthy donors and patients suffering from chronic lymphocytic leukemia. Exp Hematol. 1980 Jul;8(6):690–693. [PubMed] [Google Scholar]
- Gupta S., Good R. A., Siegal F. P. Rosette formation with mouse erythrocytes. III. Studies in patients with primary immunodeficiency and lymphoproliferative disorders. Clin Exp Immunol. 1976 Nov;26(2):204–213. [PMC free article] [PubMed] [Google Scholar]
- Scarffe J. H., Prudhoe J., Garrett J. V., Crowther D. Colchicine ultrasensitivity of peripheral-blood lymphocytes from patients with non-Hodgkin's lymphoma. Br J Cancer. 1980 Apr;41(4):593–601. doi: 10.1038/bjc.1980.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schrek R. Letter: Sensitivity to colchicine as a test for leukemic lymphocytes. N Engl J Med. 1975 Jul 17;293(3):151–151. doi: 10.1056/NEJM197507172930316. [DOI] [PubMed] [Google Scholar]
- Schrek R., Molnar Z., Stefani S. S. Cytology and colchicine sensitivity of viable cells from lymph nodes with malignant lymphoma. Cancer. 1978 May;41(5):1845–1856. doi: 10.1002/1097-0142(197805)41:5<1845::aid-cncr2820410528>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- Spengler G. A., Stjernholm R. L. A transient lymphotoxic serum factor in a patient with chronic lymphocytic leukemia. Am J Med Sci. 1972 Apr;263(4):241–252. doi: 10.1097/00000441-197204000-00006. [DOI] [PubMed] [Google Scholar]
- Sugden P. J. Letter: Autoinhibition of P.H.A. response by chronic-lymphocytic-leukaemia serum. Lancet. 1974 Sep 7;2(7880):596–597. doi: 10.1016/s0140-6736(74)91921-7. [DOI] [PubMed] [Google Scholar]
- Thomson A. E., O'Connor T. W., Wetherley-Mein G. Killing and characterizing action of colchicine in vitro on lymphocytes of chronic lymphocytic leukaemia. Scand J Haematol. 1972;9(3):231–247. doi: 10.1111/j.1600-0609.1972.tb00936.x. [DOI] [PubMed] [Google Scholar]